Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids
by
Holtzman, Matthew P.
, Pai, Reetesh K.
, Shuai, Yongli
, Jones, Heather
, Choudry, Haroon A.
, Bartlett, David L.
, Radomski, Michal
, Ramalingam, Lekshmi
, Zeh, Herbert J.
, Ahrendt, Steven A.
, Pingpank, James F.
in
Antineoplastic Agents - administration & dosage
/ Appendiceal Neoplasms - classification
/ Appendiceal Neoplasms - pathology
/ Carcinoid Tumor - classification
/ Carcinoid Tumor - pathology
/ Carcinoid Tumor - secondary
/ Carcinoid Tumor - therapy
/ Chemotherapy, Adjuvant
/ Combined Modality Therapy - methods
/ Cytoreduction Surgical Procedures
/ Female
/ Gastrointestinal Oncology
/ Goblet Cells
/ Humans
/ Hyperthermia, Induced
/ Kaplan-Meier Estimate
/ Lymphatic Metastasis
/ Male
/ Medicine
/ Medicine & Public Health
/ Middle Aged
/ Neoadjuvant Therapy
/ Oncology
/ Peritoneal Neoplasms - classification
/ Peritoneal Neoplasms - pathology
/ Peritoneal Neoplasms - secondary
/ Peritoneal Neoplasms - therapy
/ Proportional Hazards Models
/ Retrospective Studies
/ Surgery
/ Surgical Oncology
/ Survival Rate
2016
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids
by
Holtzman, Matthew P.
, Pai, Reetesh K.
, Shuai, Yongli
, Jones, Heather
, Choudry, Haroon A.
, Bartlett, David L.
, Radomski, Michal
, Ramalingam, Lekshmi
, Zeh, Herbert J.
, Ahrendt, Steven A.
, Pingpank, James F.
in
Antineoplastic Agents - administration & dosage
/ Appendiceal Neoplasms - classification
/ Appendiceal Neoplasms - pathology
/ Carcinoid Tumor - classification
/ Carcinoid Tumor - pathology
/ Carcinoid Tumor - secondary
/ Carcinoid Tumor - therapy
/ Chemotherapy, Adjuvant
/ Combined Modality Therapy - methods
/ Cytoreduction Surgical Procedures
/ Female
/ Gastrointestinal Oncology
/ Goblet Cells
/ Humans
/ Hyperthermia, Induced
/ Kaplan-Meier Estimate
/ Lymphatic Metastasis
/ Male
/ Medicine
/ Medicine & Public Health
/ Middle Aged
/ Neoadjuvant Therapy
/ Oncology
/ Peritoneal Neoplasms - classification
/ Peritoneal Neoplasms - pathology
/ Peritoneal Neoplasms - secondary
/ Peritoneal Neoplasms - therapy
/ Proportional Hazards Models
/ Retrospective Studies
/ Surgery
/ Surgical Oncology
/ Survival Rate
2016
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids
by
Holtzman, Matthew P.
, Pai, Reetesh K.
, Shuai, Yongli
, Jones, Heather
, Choudry, Haroon A.
, Bartlett, David L.
, Radomski, Michal
, Ramalingam, Lekshmi
, Zeh, Herbert J.
, Ahrendt, Steven A.
, Pingpank, James F.
in
Antineoplastic Agents - administration & dosage
/ Appendiceal Neoplasms - classification
/ Appendiceal Neoplasms - pathology
/ Carcinoid Tumor - classification
/ Carcinoid Tumor - pathology
/ Carcinoid Tumor - secondary
/ Carcinoid Tumor - therapy
/ Chemotherapy, Adjuvant
/ Combined Modality Therapy - methods
/ Cytoreduction Surgical Procedures
/ Female
/ Gastrointestinal Oncology
/ Goblet Cells
/ Humans
/ Hyperthermia, Induced
/ Kaplan-Meier Estimate
/ Lymphatic Metastasis
/ Male
/ Medicine
/ Medicine & Public Health
/ Middle Aged
/ Neoadjuvant Therapy
/ Oncology
/ Peritoneal Neoplasms - classification
/ Peritoneal Neoplasms - pathology
/ Peritoneal Neoplasms - secondary
/ Peritoneal Neoplasms - therapy
/ Proportional Hazards Models
/ Retrospective Studies
/ Surgery
/ Surgical Oncology
/ Survival Rate
2016
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids
Journal Article
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids
2016
Request Book From Autostore
and Choose the Collection Method
Overview
Background
The impact of histopathologic features on oncologic outcomes for patients with peritoneal metastases from goblet cell carcinoid (GCC) undergoing multimodality therapy, including cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC), is unknown.
Methods
This study prospectively analyzed 43 patients with GCC undergoing CRS-HIPEC between 2005 and 2013. Pathology slides were re-reviewed to classify GCC into histologic subtypes according to the Tang classification. Kaplan–Meier survival curves and multivariate Cox-regression models identified prognostic factors affecting oncologic outcomes.
Results
The 43 patients in this study underwent 50 CRS-HIPEC procedures for peritoneal metastases from GCC, and the majority received neoadjuvant and/or adjuvant systemic chemotherapy. The GCC demonstrated an aggressive phenotype with frequent lymph node and peritoneal metastases without systemic dissemination. The majority of the patients had Tang B GCC. The estimated median overall survival times after surgery for the patients with Tang A, B, and C GCC were respectively 59, 22, and 13 months. In a multivariate Cox-regression analysis, poor survival was associated with patients who had Tang B or C GCC, those undergoing incomplete macroscopic resection, and those with symptoms at the time of CRS-HIPEC. The patients with Tang A GCC demonstrated oncologic outcomes similar to those with intermediate-grade (American Joint Committee on Cancer [AJCC] grade 2) disseminated mucinous appendiceal neoplasms, whereas the patients with Tang B and C GCC demonstrated survival rates similar to or worse than those with high-grade (AJCC grade 3) disseminated mucinous appendiceal neoplasms.
Conclusions
Tang classification is an independent prognostic factor for poor survival after multimodality therapy for GCC. Patients with Tang C GCC demonstrate limited survival and are not ideal candidates for a surgical approach.
Publisher
Springer International Publishing,Springer Nature B.V
Subject
Antineoplastic Agents - administration & dosage
/ Appendiceal Neoplasms - classification
/ Appendiceal Neoplasms - pathology
/ Carcinoid Tumor - classification
/ Combined Modality Therapy - methods
/ Cytoreduction Surgical Procedures
/ Female
/ Humans
/ Male
/ Medicine
/ Oncology
/ Peritoneal Neoplasms - classification
/ Peritoneal Neoplasms - pathology
/ Peritoneal Neoplasms - secondary
/ Peritoneal Neoplasms - therapy
/ Surgery
This website uses cookies to ensure you get the best experience on our website.